• Je něco špatně v tomto záznamu ?

MicroRNAs as potential markers of parenteral nutrition associated liver disease in adult patients

M. Cahová, H. Daňková, M. Heczková, M. Brátová, N. Ďásková, H. Baštová, J. Gojda, P. Wohl

. 2019 ; 68 (4) : 681-688. [pub] 20190606

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20005475

Grantová podpora
NV15-28745A MZ0 CEP - Centrální evidence projektů

Parenteral nutrition-associated liver disease (PNALD) is a severe complication in patients completely dependent on parenteral nutrition (PN). The gold diagnostic standard, liver biopsy, is associated with significant health risk and therefore its use is limited. MicroRNAs (miRNAs) are small non-coding regulatory RNA molecules with highly tissue-specific expression and the secreted miRNAs may serve as non-invasive diagnostic biomarkers. The aim of this study was to evaluate the expression of a panel of specific miRNAs associated with liver diseases of different origin in PN-dependent adult patients in order to design miRNA panel enabling to precise monitoring of PNALD progression. Twelve PN-dependent patients with short bowel syndrome (SBS) were monitored on three/four-month basis for up to 24 months. Forty-five age- and sex-matched subjects without any known liver pathology served as controls. Specific miRNAs expression was determined by RT-qPCR using TaqMan probes (Thermofisher). Liver function test parameters were determined in certified clinical laboratories. Six of the tested miRNAs exhibited significantly altered expression compared with healthy controls, three of them (MIR122, MIR1273g, and MIR500a) were upregulated while three were down-regulated (MIR505, MIR199a, MIR139). MIR122 positively correlated with serum AST and ALT activities while MIR1273g positively correlated with serum CRP concentration and GGT activity. MIR505, MIR199a, and MIR139 negatively correlated with serum GGT activity. Fluctuation of these parameters well paralleled serum miRNA concentrations in all patients throughout the whole observation period. We identified six miRNAs whose serum concentrations are significantly altered in PN-dependent patients with PNALD and correlate with markers of inflammation, cholestasis or hepatic injury. Their reliability as markers of PNALD progression needs to be further evaluated.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc20005475
003      
CZ-PrNML
005      
20201023113934.0
007      
ta
008      
200511s2019 xr f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.934103 $2 doi
035    __
$a (PubMed)31177800
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Cahová, Monika $7 xx0070633 $u Centre of Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
245    10
$a MicroRNAs as potential markers of parenteral nutrition associated liver disease in adult patients / $c M. Cahová, H. Daňková, M. Heczková, M. Brátová, N. Ďásková, H. Baštová, J. Gojda, P. Wohl
504    __
$a Literatura
520    9_
$a Parenteral nutrition-associated liver disease (PNALD) is a severe complication in patients completely dependent on parenteral nutrition (PN). The gold diagnostic standard, liver biopsy, is associated with significant health risk and therefore its use is limited. MicroRNAs (miRNAs) are small non-coding regulatory RNA molecules with highly tissue-specific expression and the secreted miRNAs may serve as non-invasive diagnostic biomarkers. The aim of this study was to evaluate the expression of a panel of specific miRNAs associated with liver diseases of different origin in PN-dependent adult patients in order to design miRNA panel enabling to precise monitoring of PNALD progression. Twelve PN-dependent patients with short bowel syndrome (SBS) were monitored on three/four-month basis for up to 24 months. Forty-five age- and sex-matched subjects without any known liver pathology served as controls. Specific miRNAs expression was determined by RT-qPCR using TaqMan probes (Thermofisher). Liver function test parameters were determined in certified clinical laboratories. Six of the tested miRNAs exhibited significantly altered expression compared with healthy controls, three of them (MIR122, MIR1273g, and MIR500a) were upregulated while three were down-regulated (MIR505, MIR199a, MIR139). MIR122 positively correlated with serum AST and ALT activities while MIR1273g positively correlated with serum CRP concentration and GGT activity. MIR505, MIR199a, and MIR139 negatively correlated with serum GGT activity. Fluctuation of these parameters well paralleled serum miRNA concentrations in all patients throughout the whole observation period. We identified six miRNAs whose serum concentrations are significantly altered in PN-dependent patients with PNALD and correlate with markers of inflammation, cholestasis or hepatic injury. Their reliability as markers of PNALD progression needs to be further evaluated.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a kohortové studie $7 D015331
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a nemoci jater $x diagnóza $x etiologie $x krev $7 D008107
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mikro RNA $x krev $7 D035683
650    _2
$a lidé středního věku $7 D008875
650    _2
$a parenterální výživa $x škodlivé účinky $x trendy $7 D010288
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Daňková, Helena $7 xx0239615 $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague
700    1_
$a Heczková, Marie $7 xx0102189 $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague
700    1_
$a Brátová, Miriam $7 xx0248520 $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague
700    1_
$a Ďásková, Nikola. $7 xx0256836 $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague
700    1_
$a Baštová, H. $7 _AN083646 $u Diabetes Center, Institute for Clinical and Experimental Medicine, Prague
700    1_
$a Gojda, Jan, $d 1983- $7 xx0212530 $u Second Department of Medicine, University Hospital Královské Vinohrady and Third Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Wohl, Petr, $d 1970- $7 xx0054426 $u Diabetes Center, Institute for Clinical and Experimental Medicine, Prague
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 68, č. 4 (2019), s. 681-688
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31177800 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20201023113932 $b ABA008
999    __
$a ok $b bmc $g 1530829 $s 1095530
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 68 $c 4 $d 681-688 $e 20190606 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
GRA    __
$a NV15-28745A $p MZ0
LZP    __
$b NLK118 $a Pubmed-20200511

Najít záznam

Citační ukazatele

Možnosti archivace